Trinity Biotech (TRIBY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY)

TRIB 0.990

+3.2%

10:16 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: UncleWaltie who wrote (9687)	7/8/1998 4:31:00 PM
From: DELT1970	Read Replies (1) of 14328

It's a nice public relations/B-holder-friendly move away from the emphatic, "no extension," uttered on the last conference call. But then it was only a few calls ago when we heard there was no interest in substance abuse testing, either. I think I'm more concerned about near term revenue expansion than dilution from warrants, as it would require a 50% move from here. The obvious play remains the common stock/ADR. Interesting that assets can be bought for 1 x revenues; let's buy more and unlock the SLF equity. Also on my wish list: a PR campaign focused on highlighting our Unigold technology platform and why it may be of similar importance going forward as the EPS focus. Thanks, Bray.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next